More articles from GI

You have access
Impact of Y-90 glass microspheres residue measurement post-TARE using PET/CT on the tumor absorbed dose in comparison to planned dosimetry with Tc99m MAA scintigraphy.
Sarah Boughdad, Rafael DURAN, John Prior, Michael Mota, Melanie Mendes De Carvalho, Julien Costes, Silvano Gnesin and Niklaus Schaefer

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 3038;
You have access
Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: Comparison with conventional PET/CT
Yan Hu, Guobing Liu and Hongcheng Shi

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 3025;
You have access
The clinical usefulness of FDG-PET / CT parameters for predicting prognosis of patients of superficial esophageal squamous cell carcinoma diagnosed on endoscopy.
Arman Nessipkhan and Takashi Kudoh

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 3019;
You have access
Prediction of liver hypertrophy in patients undergoing Y-90 radioembolization treatment
Xinchi Hou, Anastasia Hadjivassiliou, Ivan Klyuzhin, Francois Benard, David Liu and Arman Rahmim

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 3027;
You have access
Diagnostic Value of Integrated PET/MRI in Postoperative Recurrence of Pancreatic Cancer
Chenjie Xu and Yuanfan Xu

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 3032;
You have access
Role of FDG PET based metabolic tumor volume (MTV) in prognostication of locally advanced gallbladder carcinoma
Shantanu Pande, Nihit Mhatre, Zaeba Nayeem and Jyoti Ranjan Swain

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 3021;
You have access
Near Real-Time Y-90 Dose Infusion Monitoring and On-table Assessment of Residual Dose
Dustin Osborne, Gregory Minwell, Bradley Pollard, D. Chris Walker, Shelley Acuff, Kristen Smith and Christopher Stephens

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 3037;
You have access
188Re-SSS lipiodol radioembolization in HCC patients: results of a phase one study.
Etienne Garin, Xavier Palard, Christelle Bouvry, Yan Rolland, SAMUEL LE SOURD, Nicolas LEPAREUR, Valérie Ardisson, Sophie Laffont, Boris Campillo-Gimenez, Eric Bellissant and Julien Edeline

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 3020;
You have access
Distribution of Post-Infusion Free Y-90 In Radioembolization Therapies
Dustin Osborne, Gregory Minwell, Bradley Pollard, D. Chris Walker, Shelley Acuff, Kristen Smith and Christopher Stephens

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 3036;
You have access
Predictive significance of heterogeneity parameters and metabolic parameters of 18F-FDG PET/CT in distinguishing MSI status of non-metastatic colorectal carcinoma
Li Zhang and Wei Cao

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 3033;

Main menu

User menu

Search

More articles from GI

Pages